Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention

Mohana Rupa L; Lalitha S V; Pravallika Dasari; Krishna Chaitanya Rudaraju; Jagan Nadipelly

doi:10.5455/njppp.2019.9.0727320092019

2026, Vol: 16, Issue: 2

16 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

« Previous Article

Original Research
Online Published: 24 Sep 2019

Natl J Physiol Pharm Pharmacol. 2019; 9(12): 1190-1192

doi: 10.5455/njppp.2019.9.0727320092019

Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention

Mohana Rupa L, Lalitha S V, Pravallika Dasari, Krishna Chaitanya Rudaraju, Jagan Nadipelly.

Abstract
Background: Nephropathy induced by contrast media used in angiographic procedure is a very common complication and found third most common cause of hospital-acquired acute renal injury. There is no gold standard drug therapy for the management of this condition.

Aims and Objectives: The present study is designed to evaluate the preventive role of N-acetylcysteine (NAC) in contrast-induced nephropathy (CIN) in susceptible patients receiving intravascular contrast media for coronary angiogram (CAG) and percutaneous transluminal coronary angioplasty (PTCA). Materials and Methods: The patients scheduled for elective CAG or PTCA, who were induced with radiocontrast media such as Omnipaque (140350 ml) and Visipaque (320 mg/ml) were included in the study. The baseline data of serum creatinine (SCR) were measured during 0 h, i.e., prior catheterization referred to as baseline and 24 h, 48 h, and 72 h after contrast administration. The above readings were noted for both the groups where one received NAC plus hydration (1200 mg, orally, twice a day for 48 h) and other group received hydration therapy alone.

Results: In the study, among the total (326) patients, 149 were treated only with hydration therapy and the mean of SCR levels of these patients before the procedure, that is, at 0 h and after the procedure at 24 h, 48 h, and 72 h is found to be 1.5245, 1.4138, 1.7966, and 0.4899, respectively, and remaining 177 were treated with NAC plus hydration therapy and the mean of the SCR levels of these patients before the procedure, that is, at 0 h and after the procedure at 24 h, 48 h, and 72 h is found to be 1.1616, 1.1546, 0.3586, and 0.01708, respectively.

Conclusion: Based on the above results, it has been proven that NAC administration through oral route has prevented the CIN after cardiovascular procedures.

Key words: Serum Creatinine; Renal Injury; Contrast-induced Nephropathy

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Mohana Rupa L Articles by Lalitha S V Articles by Pravallika Dasari Articles by Krishna Chaitanya Rudaraju Articles by Jagan Nadipelly
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

L MR, V LS, Dasari P, Rudaraju KC, Nadipelly J. Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention. Natl J Physiol Pharm Pharmacol. 2019; 9(12): 1190-1192.

doi:10.5455/njppp.2019.9.0727320092019

Web Style

L MR, V LS, Dasari P, Rudaraju KC, Nadipelly J. Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention. https://www.njppp.com/?mno=58371 [Access: June 27, 2026].

doi:10.5455/njppp.2019.9.0727320092019

AMA (American Medical Association) Style

L MR, V LS, Dasari P, Rudaraju KC, Nadipelly J. Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention. Natl J Physiol Pharm Pharmacol. 2019; 9(12): 1190-1192.

doi:10.5455/njppp.2019.9.0727320092019

Vancouver/ICMJE Style

L MR, V LS, Dasari P, Rudaraju KC, Nadipelly J. Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention. Natl J Physiol Pharm Pharmacol. (2019), [cited June 27, 2026]; 9(12): 1190-1192.

doi:10.5455/njppp.2019.9.0727320092019

Harvard Style

L, M. R., V, . L. S., Dasari, . P., Rudaraju, . K. C. & Nadipelly, . J. (2019) Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention. Natl J Physiol Pharm Pharmacol, 9 (12), 1190-1192.

doi:10.5455/njppp.2019.9.0727320092019

Turabian Style

L, Mohana Rupa, Lalitha S V, Pravallika Dasari, Krishna Chaitanya Rudaraju, and Jagan Nadipelly. 2019. Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention. National Journal of Physiology, Pharmacy and Pharmacology, 9 (12), 1190-1192.

doi:10.5455/njppp.2019.9.0727320092019

Chicago Style

L, Mohana Rupa, Lalitha S V, Pravallika Dasari, Krishna Chaitanya Rudaraju, and Jagan Nadipelly. "Role of N-acetylcysteine in prevention of contrast-induced nephropathy among inpatients undergoing coronary angiogram and percutaneous intervention." National Journal of Physiology, Pharmacy and Pharmacology 9 (2019), 1190-1192.

doi:10.5455/njppp.2019.9.0727320092019

MLA (The Modern Language Association) Style

doi:10.5455/njppp.2019.9.0727320092019

APA (American Psychological Association) Style

doi:10.5455/njppp.2019.9.0727320092019

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article